alexa Abstract | Orphan Drugs

Indian Journal of Pharmaceutical Sciences
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article Open Access


As per the United States Food and Drug Administration, orphan drugs are defined as drugs used in diseases or circumstances which occur so infrequently in USA, that there is no reasonable expectation that the cost of developing and making available, a drug for such disease or condition will be recovered from its sales in USA. In this article, the current state of orphan drugs in different countries and the benefits provided by the drug authorities/government of the country for the development of drugs for rare disease is discussed.

To read the full article Peer-reviewed Article PDF image

Author(s): Meera Sumanth S Parasher

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version